CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Unaudited) (USD $) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Net revenues	$ 18,295,130	$ 18,134,158	$ 60,946,404	$ 43,115,517
Costs and operating expenses:
Cost of product sales	9,571,818	7,759,761	33,811,615	15,861,461
Selling, general and administrative expense	11,739,675	9,837,217	38,960,310	24,302,513
Research and development expense	633,419	332,971	3,632,719	511,694
Loss from the operations of the joint venture with SEEK				240,195
Depreciation and amortization expense	2,672,291	885,982	7,466,991	2,320,589
(Gain) loss on sale of assets	(3,601)		1,279
Total costs and operating expenses	24,613,602	18,815,931	83,872,914	42,236,452
Loss from operations	(6,318,472)	(681,773)	(22,926,510)	(120,935)
Other income (expense):
Change in fair value of put right	(2,145,700)		(6,116,489)
Change in fair value of contingent consideration	522,000		805,000
Interest expense, net	(782,782)	7,431	(3,491,966)	(59,976)
Gain on sale of investment			3,605,000
Total other (loss) income, net	(2,406,482)	7,431	(5,198,192)	(59,976)
Loss before income taxes	(8,724,954)	(674,342)	(28,124,702)	(180,911)
Income tax (benefit) provision	(2,676,000)	(404,000)	(8,060,000)	(170,000)
Net Loss	(6,048,954)	(270,342)	(20,064,702)	(10,911)
Reclassification adjustment for net realized gain included in net income (loss), net of income tax		808,374	(2,975,118)	2,286,874
Comprehensive (Loss) income	$ (6,048,954)	$ 538,032	$ (23,039,820)	$ 2,275,963
Net Loss per share, basic	$ (0.16)	$ (0.01)	$ (0.55)	$ 0
Net Loss per share, diluted	$ (0.16)	$ (0.01)	$ (0.55)	$ 0
Weighted-average common shares, basic	37,120,890	29,069,119	36,204,340	27,765,275
Weighted-average common shares, diluted	37,120,890	29,069,119	36,204,340	27,765,275